Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab

In conclusion, our data provide evidence of molecular mechanisms contributing to the progression of HER2 + breast cancers and could facilitate the development of therapeutic options to counteract resistance to anti-HER2 therapies.